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The beta subunit of human chorionic gonadotrophin (hCGb)
confers the structural and functional identity of the biologically
active glycoprotein heterodimer of hCG. The alpha subunit is
common to all members of the glycoprotein hormone family,
which includes thyroid stimulating hormone (TSH), follicle stimu-
lating hormone (FSH) and luteinizing hormone (LH). Only the
intact a-b arrangement is hormonally functional; the free subunits
themselves do not exhibit gonadotrophic or thyrotrophic activity,
and the beta subunit alone is not sufficient to stimulate the
LH/hCG receptor (Pierce and Parsons, 1981). Therefore, any
growth factor activity exhibited is generally regarded to be occur-
ring via a novel pathway.
The ectopic production of free hCGb – in the absence of 
the alpha subunit – is a well-recognized phenomenon in many
epithelial tumours (Braunstein, 1983; Iles and Chard, 1989). It 
was originally regarded as an epiphenomenon, with no biological
significance given the absence of hCGa and a functional hetero-
dimeric structure. More recently, however, it has been shown that
the beta subunit may have its own unique functions. Lunardi-
Iskander et al (1995) and Gillott et al (1996) have independently
shown growth inhibitory and growth stimulatory effects of free
hCGb. Elucidation of the crystal structure of hCG revealed
surprising topological similarities with the known ‘cystine knot’
growth factors – transforming growth factor beta (TGF-b), platelet
derived growth factor beta (PDGFb) and nerve cell growth factor
(NGF). In particular, hCGb and its urinary breakdown product, the
hCGb core fragment (hCGbcf), bear a striking similarity to TGFb
and PDGFb respectively (Lapthorn et al, 1994). Furthermore, the
growth factor family also share a common feature of only func-
tioning as hetero- and/or homodimers and investigations into
hCGb as a cystine knot growth factor have shown that, along with
the established heterodimeric structure of the hormone hCG,
hCGb and hCGbcf also form homodimers (Butler et al, 1999; Iles
et al, 1999).
These surprising new findings support the hypothesis that the
ectopic production of hCGb by epithelial tumours is not an
epiphenomenon, but rather a significant release of a possible
autocrine/paracrine growth factor which is contributing directly to
the poor prognosis of these tumours. Further studies into the
stimulation of bladder carcinoma cells with recombinant hCGb
continue to bring about an increase in cell number when quantified
by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide
(MTT) reduction. However, cell replication – as quantified by
thymidine incorporation (unpublished data) – is not consistent
with the same increase in population, suggesting that the hCGb is
not, in fact, increasing the growth rate, but rather is slowing the
rate of apoptosis. Here we have investigated apoptosis in bladder
carcinoma cell lines in response to hCGb stimulation.
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Summary Ectopic production of free beta human chorionic gonadotrophin (hCGb) by bladder carcinoma is well described and occurs in
approximately 35% of cases. hCGb secreting tumours are more aggressive, radioresistant and have a greater propensity to metastasize. We
proposed that the ectopic production of hCGb was contributing in an autocrine fashion to the radioresistance and metastatic potential of such
secreting tumours. Though we demonstrated that the addition of hCGb to the culture media of bladder, cervical and endometrial carcinoma
cell lines brought about an increase in cell populations this was not accompanied by a significant increase in the rate of replication. Since a
cell population size is a balance of mitosis and mortality, we proposed that hCGb was inhibiting apoptosis. Here we have demonstrated that
following incubation with recombinant hCGb, bladder carcinoma cells refrain from undergoing apoptosis. Quantitation of apoptotic bodies was
carried out by immunoassay and corrected to cell number as determined by MTT assay. In each cell line, addition of hCGb reduced the
number of apoptotic bodies dose-dependently, indicating a diminished apoptotic rate. Furthermore, TGFb1-induced apoptosis could be dose-
dependently inhibited by co-incubation with hCGb. We propose, therefore, that such a decline in apoptosis may account for the cell population
increase previously reported. It may also explain the radioresistance and aggressive nature of hCGb-secreting tumours and the poor
prognosis associated therein. © 2000 Cancer Research Campaign
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Growth factors
Recombinant hCGb and recombinant TGFb1 (Sigma, Poole, UK)
were reconstituted according to the manufacturer’s recommenda-
tions. Aliquots of reconstituted proteins were diluted to working
concentrations in RPMI-1640 cell culture medium (Sigma)
containing 10% fetal calf serum (FCS) and 1% antibiotic/antimy-
cotic solution (Gibco-BRL, Life Technologies Ltd, Paisley, UK).
Cell lines
Bladder carcinoma cell lines T24 (Dr J Masters, Institute of
Urology, London, UK), SCaBER, J82, 5637 and RT112
(American type Culture Collection, Rockville, MD, USA) were
used in the incubation studies. T24 has been shown to be the most
sensitive to the addition of hCGb believed to be due to the fact that
it produces no endogenous hCGb of its own (Gillott et al, 1996).
SCaBER and RT112 are high level hCGb producers and 5637 and
J82 low level hCGb producers (Iles and Chard, 1989).
MTT assay
A variation on the MTT assay (Mosman, 1983; Twentyman and
Luscome, 1987) was used to determine cell numbers following an
incubation with a growth factor or combination of growth factors.
Ninety-six-well plates (Flat-bottomed, Nunc, Gibco-Life
Technologies) were seeded with 5 ´ 104 cells per well, in RPMI-
1640/10% FCS/1% antibiotic antimycotic and incubated at 37°C
in the presence of 5% carbon dioxide for 24 h. The media were
then replaced with new media containing the growth factor
material (0–400 pmol ml–1), in replicates of 6 and incubated as
before, for a period of 48 h. Control plates were treated with the
same concentrations of TGF-b1, a known inducer of epithelial cell
apoptosis and a member of the same family of growth factors as
hCGb. In the co-incubation experiments apoptosis was induced by
incubation in 100 pmol ml–1 TGF-b1 in addition to increasing
concentrations (0–400 pmol ml–1) of hCGb. Following this, the
cells were subjected to MTT assay. Media was again replaced with
RPMI without phenol red and further incubated for a period of 1 h,
upon which 20 ml of sterile filtered MTT (Sigma) (5 mg ml–1 in
phosphate-buffered saline) was added to each well. After a 3-h
incubation all solutions were removed from the cells and replaced
with 200 ml of dimethylsulphoxide (DMSO, Sigma, UK) and the
formizan crystals allowed to dissolve. Each well was then read for
absorbance at 570 nm in a Microplate autoreader (Bio-Tek instru-
ments).
Prior to MTT assay an aliquot of incubation media was removed
from each well and assayed for the presence of mono- and
oligonucleosomes using the Boehringer Mannheim apoptosis cell
death detection enzyme-linked immunosorbent assay. Nucleosome
concentration was then determined from the spectrophotometric
data and corrected to cell number as subsequently determined by
tetrazolium salt reduction.
RESULTS
Absorbance data were corrected to percentage change from
untreated control. The percentage change in cell number and
percentage change in nucleosome concentration clearly indicate a
rise in cell number accompanied by a corresponding fall in nucle-
osome concentration in response to hCGb. Conversely TGF-b1
brings about a dose-dependent fall in cell number and rise in
nucleosome concentration (Figure 1 A, B). Figure 2 indicates the
results of the co-incubation study, a sharp rise in the percentage
number of nucleosomes (and hence increase in apoptosis)
following incubation with 100 pmol ml–1 TGF-b1. The effect grad-
ually diminishes to below 100% as the concentration of hCGb
increases from 0 to 400 pmol ml–1, despite the continued presence
of TGFb1.
DISCUSSION
The ectopic production of free hCGb is a well-recognized
phenomenon in many epithelial tumours (Cole et al, 1988). It is
now apparent that this event may significantly affect tumour
development given the growth effects recently described (Lunardi-
Iskander et al, 1995; Gillott et al, 1996). It is accepted that free
hCGb is unable to activate the LH/hCG receptor and stimulate the
subsequent second messengers. Therefore the recently reported
growth factor activities of hCGb are assumed to proceed via novel,
and as yet unidentified, pathways. Following the elucidation of
hCG’s crystal structure, its subunits were grouped with the family
of cystine knot growth factors which includes TGF, PDGF and
NGF (Lapthorn et al, 1994). The topological similarities observed
– particularly the presence of the central cystine knot – suggest a
common growth factor function. This concept has recently been
reinforced by data which clearly indicate the presence of hCGb
homodimers that, like TGF, PDGF and NGF, may be required to
bring about cellular growth responses.
In this study we have reconfirmed the apparent growth stimula-
tion of bladder carcinoma cells by hCGb in comparison to the
effect brought about by TGF-b1, a cystine knot growth factor and
known inducer of epithelial apoptosis (Sporn et al, 1986; Sun and
Davies, 1995). Figure 1A shows the contrasting effects of TGF-
b1 and hCGb on cell number in five bladder carcinoma cell lines.
The change in apoptosis in response to hCGb or TGF-b1 can be
seen in Figure 1B and could certainly account for the difference in
cell number observed in the previous figure (Figure 1A). We
propose that the increase in cell number brought about by hCGb
could be solely accounted for by a reduction in apoptosis. The
sharp rise in cell numbers in response to low concentrations of
hCGb followed by a plateau indicates that the molecule may be
acting in an inhibitory fashion given that there is a sudden change
in percentage cell number at a given hCGb concentration and not
a gradual dose-dependent response. The results following co-
incubation of 5637 cells with constant TGF-b1 and increasing
hCGb indicate that hCGb can reverse the apoptotic effect brought
about by the addition of TGF-b1. An increase in nucleosome
concentration in the presence of 100 pmol ml–1 TGF-b1 is consis-
tent with that seen for 5637 in Figure 1B. However, as the hCGb
concentration increases the number of nucleosomes reduces to
below that seen in the negative control despite the presence of the
TGF-b1.
In light of the particular topological similarities between hCGb
and TGF-b and the opposing nature of their effect on epithelial
cells, it could be suggested that hCGb may be interacting with the
TGF-b receptor complex. Interactions between the cystine knot
growth factors is not uncommon, and TGF-b and PDGF in partic-
ular, cooperate to bring about their designated responses. The
hCGb homodimer recently described could be such a candidate for
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align the receptor subunits and initiate the apoptotic cascade. The
marked similarity in topology may be enough to allow binding but
not to activate second messengers in addition and thus prevent the
action of the autocrine TGF-b regulation on cell growth. The results
here do not provide the information to determine the route by which
hCGb is acting. Given the complexity of an apoptotic cascade any
cross-talk occurring may do so at any number of locations
following stimulation by hCGb and warrants further investigation.
In conclusion it appears that the recently described growth
effect attributed to ectopic free hCGb production is not due to
growth stimulation but an anti-apoptosis effect which may be
brought about in an antagonistic manner via a known receptor or
receptor-mediated cascade. Whatever the mode of action occur-
ring here the evidence for hCGb as a growth modulator is
increasing and its involvement in an apoptotic cascade opens up a
new field for investigation.
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Figure 1 (A) The percentage change in cell number from the control (100%, and indicated by the dashed line) as a result of incubation with hCGb (top) and
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by the dashed line) as a result of incubation with hCGb (bottom) and TGF-b1 (top) on the five different bladder cancer cell lines
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